NCT01996735View on ClinicalTrials.gov

Ticagrelor and Adenosine

PHASE4CompletedINTERVENTIONAL
Enrollment

14

Participants

Timeline

Start Date

April 30, 2013

Primary Completion Date

November 30, 2013

Study Completion Date

December 31, 2013

Conditions
Healthy
Interventions
DRUG

Ticagrelor 180 mg single dose

DRUG

Placebo

Trial Locations (1)

6500 HB

Radboud University Nijmegen Medical Centre, Nijmegen

All Listed Sponsors
lead

Radboud University Medical Center

OTHER

NCT01996735 - Ticagrelor and Adenosine | Biotech Hunter | Biotech Hunter